# About Fury Peptides

> About Fury Peptides — an independent research digest — About Fury Peptides: an independent, cited research digest covering three Recovery & Tissue Repair peptides — TB-500, KPV and KLOW. Not a clinic, not a vendor.

**ABOUT**

An independent reading desk for the published research behind three recovery-and-repair peptides.

## What this site is

Fury Peptides is a literature digest covering three research peptides that come up often in discussions of recovery from hard physical training: TB-500, KPV and the four-peptide blend KLOW. Every claim on this site traces back to a specific peer-reviewed paper, preclinical study, or clearly labeled community report — nothing is invented, and nothing is presented with more certainty than the underlying evidence supports.

This site is not a clinic, not a pharmacy, and not a vendor. It does not sell any peptide, does not recommend a dose for a person, and does not offer medical advice. It exists because the commercial pages selling these compounds rarely explain, clearly and honestly, what the science actually says — including where the evidence is thin, preclinical only, or built on a different molecule than the one being sold.

## How to read this site

Every quantitative claim on this site — a percentage, a dose used in a study, a species, a sample size — carries a bracketed citation number, like [1], that links to the full reference on the [references page](/references). Where a page reports what people say in online communities, it is explicitly labeled as anecdotal and kept separate from the peer-reviewed findings above it; those community reports are never treated as evidence and never paired with a specific dose.

Each compound page follows the same structure: a plain-English summary first, then what the compound is chemically, how it is proposed to work, what has actually been tested (and in which species), community-reported effects labeled as anecdotes, and cited safety cautions. The [comparison page](/compare) lines the three compounds up side by side, and the [FAQ](/faq) answers the specific questions readers most often bring to this topic.

## Editorial stance

Two of the three compounds covered here — TB-500 and KLOW's TB-500 component — carry a documented identity gap: most of the striking efficacy data were generated using the full-length parent protein, not the short fragment actually sold commercially. KPV's entire efficacy record is preclinical, with no human trials published. KLOW's four-peptide combination has never been tested as a unit. This site states each of those facts plainly rather than glossing over them, because an accurate account of the evidence — including its limits — is the entire point of a reference desk like this one.

---

Fury Peptides is a reading desk for the tissue-repair literature, not a clinic, a vendor, or a training program — read the cited studies, not the name on the door.